Source: Pharmaceutical Processing

PharmaTech: PharmaTech Recalls All Liquid Products Due to Burkholderia Cepacia Contamination

NewsPharmaTech, LLC is voluntarily recalling all liquid products due to a potential risk of product contamination with Burkholderia cepacia.Contributed Author: FDA MedWatchTopics: Recalls

Read full article »
PharmaTech's Competitors | PharmaTech's News | PharmaTech's Financials
Stay up-to-date with the latest news on PharmaTech
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Thurman Michel's photo - President & CEO of PharmaTech

President & CEO

Thurman Michel

CEO Approval Rating

90/100

Read more
Stay up-to-date with the latest news on PharmaTech